Anat Berkovitch1, Shaye Kivity2, Robert Klempfner3, Shlomo Segev4, Assi Milwidsky5, Ilan Goldenberg3, Yechezkel Sidi6, Elad Maor7. 1. Leviev Heart Institute, Sheba Medical Centre, Israel. 2. Department of Internal Medicine C, Sheba Medical Centre, Israel Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Centre, Israel Sackler School of Medicine, Tel-Aviv University, Israel. 3. Leviev Heart Institute, Sheba Medical Centre, Israel Sackler School of Medicine, Tel-Aviv University, Israel. 4. Institute for Medical Screening, Sheba Medical Centre, Israel. 5. Leviev Heart Institute, Sheba Medical Centre, Israel Department of Internal Medicine 'E', Tel-Aviv Medical Centre, Israel. 6. Department of Internal Medicine C, Sheba Medical Centre, Israel Sackler School of Medicine, Tel-Aviv University, Israel. 7. Leviev Heart Institute, Sheba Medical Centre, Israel Pinchas Borenstein Talpiot Medical Leadership Program, Sheba Medical Centre, Israel Elad.Maor@sheba.health.gov.il.
Authors: Manouchehr S Vafaee; Albert Gjedde; Nasrin Imamirad; Kim Vang; Mallar M Chakravarty; Jason P Lerch; Paul Cumming Journal: J Cereb Blood Flow Metab Date: 2015-03-31 Impact factor: 6.200